About
Edward Hodgkin is a Managing Partner at Syncona Investment Management Ltd, the investment manager behind Syncona's life sciences investment platform. He has more than 30 years of experience across pharma, biotech, and healthcare investing, and has taken operating and board roles in multiple Syncona-backed companies, including Autolus Therapeutics, Resolution Therapeutics, OMass Therapeutics, Mosaic Therapeutics, Slingshot Therapeutics, and ALTx. He previously served as Chairman of the UK BioIndustry Association and holds a degree and DPhil in Chemistry from the University of Oxford.
Areas of interest
drug discoverycell and gene therapyrare diseasesoncologycompany creation from academic sciencedrug discovery platformsbiotechliver diseasegenomic medicineimmunologylife sciencesprecision medicinegenomic medicinestranslational scienceUK biotech ecosystemUK life sciences ecosystemautoimmune disease